Evidence map›Paper›PMID 40114037›Full record

ArticleOncogene2025

Correction: Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR.

Bosen You, Yin Sun, Jie Luo, Keliang Wang, Qing Liu, Ruizhe Fang, Bingmei Liu, Fuju Chou, Ronghao Wang, Jialin Meng and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Bosen You *Department of Urology, The 4th Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Yin Sun *George Whipple Lab for Cancer Research, Departments of Pathology and Urology, and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, 14646, USA.
Jie Luo *George Whipple Lab for Cancer Research, Departments of Pathology and Urology, and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, 14646, USA.
Keliang Wang *Department of Urology, The 4th Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Qing LiuDepartment of Urology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Ruizhe FangDepartment of Urology, The 4th Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Bingmei LiuDepartment of Pathology and Cutaneous Oncology, Heilongjiang Provincial Hospital, Harbin, 150001, China.
Fuju ChouGeorge Whipple Lab for Cancer Research, Departments of Pathology and Urology, and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, 14646, USA.
Ronghao WangGeorge Whipple Lab for Cancer Research, Departments of Pathology and Urology, and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, 14646, USA.
Jialin MengGeorge Whipple Lab for Cancer Research, Departments of Pathology and Urology, and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, 14646, USA.
Chi-Ping HuangSex Hormone Research Center and Departments of Urology, China Medical University/Hospital, Taichung, 404, Taiwan.
Shuyuan YehGeorge Whipple Lab for Cancer Research, Departments of Pathology and Urology, and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, 14646, USA.ORCID http://orcid.org/0000-0002-5329-2321
Chawnshang ChangGeorge Whipple Lab for Cancer Research, Departments of Pathology and Urology, and The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, 14646, USA. chang@urmc.rochester.edu.ORCID http://orcid.org/0000-0001-8510-3516
Wanhai XuDepartment of Urology, The 4th Affiliated Hospital of Harbin Medical University, Harbin, 150001, China. xuwanhai@hrbmu.edu.cn.ORCID http://orcid.org/0000-0003-3350-2464

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40114037
PMCPMC11976268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.